International Journal of Cardiology
Volume 125, Issue 2 , Pages 191-196 , 10 April 2008

Characteristics of heart failure in the elderly — A hospital cohort registry-based study

  • Juliana Jensen

      Affiliations

    • Department of Medicine, Sahlgrenska University Hospital/Sahlgrenska, Gothenburg, Sweden
    • Corresponding Author InformationCorresponding author.
    • ,
  • Linda Hedin

      Affiliations

    • Department of Molecular & Clinical Medicine and Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Sweden
    • ,
  • Charlotte Widell

      Affiliations

    • Department of Molecular & Clinical Medicine and Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Sweden
    • ,
  • Petra Agnhom

      Affiliations

    • Department of Molecular & Clinical Medicine and Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Sweden
    • ,
  • Björn Andersson

      Affiliations

    • Department of Molecular & Clinical Medicine and Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Sweden
    • ,
  • Michael Fu

      Affiliations

    • Department of Medicine, Sahlgrenska University Hospital/Sahlgrenska, Gothenburg, Sweden

References 

  1. Thomas S, Rich MW. Epidemiology, pathophysiology, and prognosis of heart failure in the elderly. Clin Geriatr Med. 2007;23(1):1–10
  2. Rich MW. Heart failure in older adults. Med Clin North Am. 2006;90(5):863–885
  3. Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure Survey programme — a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003;24(5):464–474
  4. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme — a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24(5):442–463
  5. Liao L, Anstrom KJ, Gottdiener JS, et al. Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study. Am Heart J. 2007;153(2):245–252
  6. Rich MW. Office management of heart failure in the elderly. Am J Med. 2005;118(4):342–348
  7. Cleland JG, Goode K, Erhardt L, et al. A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET). Cardiovasc Drugs Ther. 2004;18(2):139–152
  8. Muntwyler J, Cohen-Solal A, Freemantle N, Eastaugh J, Cleland JG, Follath F. Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe. Eur J Heart Fail. 2004;6(5):663–668
  9. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557–1562
  10. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489–497
  11. White RH, McBurnie MA, Manolio T, et al. Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort. Am J Med. 1999;106:165–171
  12. Mejhert M, Holmgren J, Wändell P, et al. Diagnostic tests, treatment and follow-up in heart failure patients — is there a gender bias in the coherence to guidelines. Eur J Heart Fail. 1999;1:407–410
  13. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 1997;157:2460–2464
  14. Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003;362(9386):759–766
  15. Tamirisa KP, Aaronson KD, Koelling TM. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure. Am Heart J. 2004;148(6):971–978
  16. Ahmed A. A propensity matched study of New York Heart Association class and natural history end points in heart failure. Am J Cardiol. 2007;99(4):549–553
  17. Le Jemtel TH, Padeletti M, Jelic S. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol. 2007;49(2):171–180
  18. Ahmed A, Rich MW, Sanders PW, et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol. 2007;99(3):393–398
  19. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA. 1999;281:634–639
  20. Kerzner R, Gage BF, Rich MW. Anemia does not predict mortality in elderly patients with heart failure. Am J Geriatr Cardiol. Mar-Apr 2007;16(2):92–96

PII: S0167-5273(07)01618-X

doi: 10.1016/j.ijcard.2007.10.003

International Journal of Cardiology
Volume 125, Issue 2 , Pages 191-196 , 10 April 2008

Article Tools